Table 3 Change in disease activity - SLEDAI score over the study period
From: Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Mild- Moderate flare | Severe flare | Remission | Total (n) | |
|---|---|---|---|---|
Baseline | 11 (52.4) | 6(28.6) | 4(19.0) | 21 |
3 Weeks | 9 (42.8) | 7 (33.4) | 5 (23.8) | 21 |
6 Weeks | 6 (28.6) | 8 (38.1) | 7 (33.4) | 21 |
3 Months | 6 (28.6) | 10 (47.6) | 5 (23.8) | 21 |
6 Months | 7 (33.3) | 8 (38.1) | 6 (28.6) | 21 |
12 Months | 12 (63.0) | 4 (21.1) | 3 (15.8) | 19 |